Eledon Pharmaceuticals, Inc.
ELDN
$1.59
$0.117.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.17% | -13.86% | -10.91% | 79.28% | -6.48% |
| Total Receivables | 6.81% | -7.36% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.61% | 54.33% | -68.30% | 121.66% | -16.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 40.00% | -81.82% | -92.46% | 64.93% | 181.53% |
| Total Current Assets | -13.56% | -12.77% | -11.14% | 76.34% | -6.55% |
|
|
|||||
| Total Current Assets | -13.56% | -12.77% | -11.14% | 76.34% | -6.55% |
| Net Property, Plant & Equipment | -10.22% | -9.06% | -8.21% | 96.60% | -24.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.57% | -2.26% | -2.48% | 72.86% | -17.65% |
| Total Assets | -10.39% | -10.17% | -9.07% | 54.84% | -4.90% |
|
|
|||||
| Total Accounts Payable | -20.65% | 101.00% | -50.27% | -0.46% | 172.81% |
| Total Accrued Expenses | 23.45% | 26.73% | 9.74% | -15.72% | 78.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.98% | 3.38% | 3.50% | 68.82% | -30.86% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.21% | 49.36% | -20.66% | -7.30% | 107.29% |
|
|
|||||
| Total Current Liabilities | 4.21% | 49.36% | -20.66% | -7.30% | 107.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.49% | -15.86% | -13.28% | 103.17% | -18.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.28% | -33.24% | -21.38% | 82.97% | -79.02% |
| Total Liabilities | -0.20% | -16.79% | -21.15% | 53.86% | -70.14% |
|
|
|||||
| Common Stock & APIC | 0.51% | 0.57% | 0.63% | 22.43% | 1.97% |
| Retained Earnings | -4.68% | -3.10% | -1.83% | -14.35% | 19.84% |
| Treasury Stock & Other | 118.75% | -166.67% | -169.23% | -74.51% | -- |
| Total Common Equity | -14.12% | -7.46% | -3.01% | 55.33% | 994.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.12% | -7.46% | -3.01% | 55.33% | 994.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.12% | -7.46% | -3.01% | 55.33% | 994.69% |
|
|
|||||